BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22344546)

  • 1. Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach.
    Qiao B; Wang J; Xie J; Niu Y; Ye S; Wan Q; Ye Q
    Int J Mol Med; 2012 May; 29(5):832-40. PubMed ID: 22344546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.
    Long J; Lang ZW; Wang HG; Wang TL; Wang BE; Liu SQ
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):296-305. PubMed ID: 20525558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
    Ritorto MS; Borlak J
    J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of two portal vein tumor thrombosis associated proteins in hepatocellular carcinoma: protein disulfide-isomerase A6 and apolipoprotein A-I.
    Xu X; Wei X; Ling Q; Cheng J; Zhou B; Xie H; Zhou L; Zheng S
    J Gastroenterol Hepatol; 2011 Dec; 26(12):1787-94. PubMed ID: 21649721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma.
    Lee NP; Leung KW; Cheung N; Lam BY; Xu MZ; Sham PC; Lau GK; Poon RT; Fan ST; Luk JM
    Proteomics; 2008 May; 8(10):2136-49. PubMed ID: 18425728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma.
    Park KS; Kim H; Kim NG; Cho SY; Choi KH; Seong JK; Paik YK
    Hepatology; 2002 Jun; 35(6):1459-66. PubMed ID: 12029631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
    Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
    Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
    J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic profiling of N-linked glycoproteins identifies ConA-binding procathepsin D as a novel serum biomarker for hepatocellular carcinoma.
    Qi YJ; Ward DG; Pang C; Wang QM; Wei W; Ma J; Zhang J; Lou Q; Shimwell NJ; Martin A; Wong N; Chao WX; Wang M; Ma YF; Johnson PJ
    Proteomics; 2014 Feb; 14(2-3):186-95. PubMed ID: 24259486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential proteomic analysis of hepatocellular carcinoma.
    Corona G; De Lorenzo E; Elia C; Simula MP; Avellini C; Baccarani U; Lupo F; Tiribelli C; Colombatti A; Toffoli G
    Int J Oncol; 2010 Jan; 36(1):93-9. PubMed ID: 19956837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel proteomic biomarker panel for prediction of aggressive metastatic hepatocellular carcinoma relapse in surgically resectable patients.
    Tan GS; Lim KH; Tan HT; Khoo ML; Tan SH; Toh HC; Ching Ming Chung M
    J Proteome Res; 2014 Nov; 13(11):4833-46. PubMed ID: 24946162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hcc-2, a novel mammalian ER thioredoxin that is differentially expressed in hepatocellular carcinoma.
    Nissom PM; Lo SL; Lo JC; Ong PF; Lim JW; Ou K; Liang RC; Seow TK; Chung MC
    FEBS Lett; 2006 Apr; 580(9):2216-26. PubMed ID: 16574106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification by differential tissue proteome analysis of talin-1 as a novel molecular marker of progression of hepatocellular carcinoma.
    Kanamori H; Kawakami T; Effendi K; Yamazaki K; Mori T; Ebinuma H; Masugi Y; Du W; Nagasaka K; Ogiwara A; Kyono Y; Tanabe M; Saito H; Hibi T; Sakamoto M
    Oncology; 2011; 80(5-6):406-15. PubMed ID: 21846996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.
    Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T
    Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.
    Diao S; Zhang JF; Wang H; He ML; Lin MC; Chen Y; Kung HF
    Proteomics; 2010 Oct; 10(20):3723-31. PubMed ID: 20859956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis.
    Feng JT; Liu YK; Song HY; Dai Z; Qin LX; Almofti MR; Fang CY; Lu HJ; Yang PY; Tang ZY
    Proteomics; 2005 Nov; 5(17):4581-8. PubMed ID: 16240287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
    Kurokawa Y; Honma K; Takemasa I; Nakamori S; Kita-Matsuo H; Motoori M; Nagano H; Dono K; Ochiya T; Monden M; Kato K
    Int J Oncol; 2006 Feb; 28(2):383-91. PubMed ID: 16391793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
    Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
    Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC; Oh MJ; Choi SH; Bae CD
    ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.